XML 30 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheet Details
12 Months Ended
Dec. 31, 2011
Consolidated Balance Sheet Details [Abstract]  
Consolidated Balance Sheet Details
4. Consolidated Balance Sheet Details

Inventory, Net (in thousands)

 

                 
     December 31,  
     2011      2010  

Raw materials

   $ 5,260       $ 5,727   

Work in process

     7,338         6,454   

Finished goods

     3,653         4,861   

Deferred costs

     0         1,251   
    

 

 

    

 

 

 
     $ 16,251       $ 18,293   
    

 

 

    

 

 

 

Deferred costs represent the costs of product shipped for which recognition of revenue has been deferred.

Property and Equipment, Net (in thousands)

 

                 
     December 31,  
     2010     2010  

Machinery, equipment and tooling

   $ 11,902      $ 9,919   

Construction in progress

     5,416        6,735   

Computer equipment and software

     1,122        1,051   

Furniture and fixtures

     562        557   

Leasehold improvements

     780        780   
    

 

 

   

 

 

 

Property and equipment, at cost

     19,782        19,042   

Less accumulated depreciation

     (5,192     (3,608
    

 

 

   

 

 

 
     $ 14,590      $ 15,434   
    

 

 

   

 

 

 

Depreciation expense for the years ended December 31, 2011, 2010 and 2009 was $1,584,000, $1,428,000 and $1,017,000, respectively.

Other Assets (in thousands)

 

                 
     December 31,  
     2011      2010  

Prepaid Aradigm royalty expense

   $ 3,429       $ 3,714   

Debt acquisition costs

     1,432         113   

Deposits

     1,090         617   

Restricted cash

     200         200   
    

 

 

    

 

 

 
     $ 6,151       $ 4,644   
    

 

 

    

 

 

 

 

Accrued Expenses (in thousands)

 

                 
     December 31,  
     2011      2010  

Accrued product returns

   $ 2,446         0   

Accrued discounts and allowances

     2,153         813   

Accrued interest expense

     1,924         265   

Accrued co-promotion service fee

     1,615         1,190   

Accrued clinical expense

     945         3,629   

Warrant liability

     345         0   

Accrued royalty expenses

     303         286   

Accrued sales and marketing expenses

     153         286   

Value added tax payable

     0         989   

Other accrued expenses

     1,209         1,981   
    

 

 

    

 

 

 
     $ 11,093       $ 9,439   
    

 

 

    

 

 

 

Other Long-Term Liabilities (in thousands)

 

                 
     December 31,  
     2011      2010  

Astellas tail payments

   $ 4,016       $ 0   

Embedded derivatives

     845         0   

Term loan final payment

     642         203   

Deferred Rent

     303         360   

Other long-term liabilities

     85         97   
    

 

 

    

 

 

 
     $ 5,891       $ 660